
Hani Goodarzi
@genophoria
Core Investigator @arcinstitute | Associate Professor @Ucsf_Biochem @UCSFurology @UCSFCancer | {Computational, Cancer, RNA} biologist
ID: 48013192
http://goodarzilab.ucsf.edu 17-06-2009 16:18:32
4,4K Tweet
5,5K Followers
1,1K Following

This was a fun one ā new Endpoints Slack interview with Patrick Hsu: endpts.com/endpoints-slacā¦

1/ š§µ THREAD: Hereās how we solved a 30-year mystery about an HIV drug. š A drug used for over two decades ā ļø Pulled from the market for cardiac risk 𤯠And no one knew why ā until now We found the missing mechanism using our single-cell mosaic dataset, Tahoe-100M. Letās talk


We're hiring! Our group Arc Institute and Stanford University has postdoc openings in 1) discovering and developing next-generation therapeutic delivery vehicles, and 2) tracking cellular dynamics. Email me if you're interested! hornslab.org


āI think youād be shocked how often people are willing to chat and help you out.ā Breaking into AI for Science can feel intimidating. Thatās why I found Alishba Imran 's story so inspiring: an undergrad at UC Berkeley, she carved her own path through study groups, shadowing

Join us today for the BMG Seminar Speaker Dr. Hani Goodarzi! Hani Goodarzi Hosted by Dr. Saeid Parast Saeid Parast Shilatifard Lab #epigenetics #oncology Northwestern Feinberg School of Medicine Northwestern Medicine Arc Institute UCSF Biochemistry UCSF Helen Diller Family Comprehensive Cancer Ctr




Sad to have missed this! Itās a Tahoe weekend! Go Tahoe Therapeutics (Formerly Vevo)

Shoot for the moon. Build openly. That's the spirit of Tahoe Therapeutics (Formerly Vevo) #tahoedeepdive. 40 people from across the world, self-organized into teams to play with Tahoe-100M and build open models of how biology interacts with chemistry.




Delighted to publicly launch @Stylus_Medicine today to program the human body into a cell therapy factory to fight cancer. It's a privilege to work with Emile and Jason as CEO/CSO of Stylus and our earliest believers Josh Resnick/Ness Bermingham from RA Capital + Khosla Ventures


Genomes encode biological complexity, which is determined by combinations of DNA mutations across millions of bases In new Arc Institute work, we report the discovery and engineering of the first programmable DNA recombinases capable of megabase-scale human genome rearrangement




The Arc Institute keeps crushing it. Big step up in specificity and insertion efficiency for human genome engineering with bridge RNAs.

"In new Arc Institute work, we report the discovery and engineering of the first programmable DNA recombinases capable of megabase-scale human genome rearrangement."
